Neuroendocrine correlates of chronic fatigue syndrome: a brief review.
Demitrack, M A · Journal of psychiatric research · 1997 · DOI
Quick Summary
This review examines how ME/CFS might be connected to problems with the body's stress hormone system and brain chemistry. Researchers found that people with ME/CFS often have a specific pattern of disruption in their stress response system—different from what occurs in depression—along with changes in serotonin levels. These findings suggest that ME/CFS involves real biological changes, not just psychological factors.
Why It Matters
This work provides biological validation for ME/CFS as a distinct neurobiological condition rather than purely psychological illness, supporting ongoing mechanistic research. Identifying specific HPA axis and serotonergic abnormalities creates potential targets for future therapeutic interventions and helps distinguish ME/CFS from depression, improving diagnostic accuracy and treatment approaches.
Observed Findings
Replicated evidence of disrupted HPA axis function in ME/CFS patients
A pattern of sustained inactivation of central nervous system stress response components (different from depression's increased cortisol pattern)
Alterations in central serotonergic tone in ME/CFS
Clinical overlap between ME/CFS and major depression despite distinct neuroendocrine patterns
Mood and anxiety disturbances prominent in ME/CFS alongside fatigue symptoms
Inferred Conclusions
ME/CFS involves measurable dysfunction in the neuroendocrine system, particularly in HPA axis regulation
The pattern of HPA axis dysregulation in ME/CFS differs qualitatively from that in melancholic depression, suggesting these are distinct conditions
Central serotonergic abnormalities contribute to ME/CFS pathophysiology
ME/CFS has biological underpinnings despite clinical similarities to psychiatric conditions
Remaining Questions
What causes the specific pattern of HPA axis inactivation in ME/CFS?
How do serotonergic alterations mechanistically relate to fatigue and other ME/CFS symptoms?
What This Study Does Not Prove
This review does not establish causation—only that certain neuroendocrine alterations correlate with ME/CFS symptoms. It does not explain why these specific changes occur or whether they represent primary dysfunction or secondary consequences of the illness. The findings also do not prove that neuroendocrine abnormalities alone fully explain ME/CFS pathophysiology, as other systems may be involved.
Do neuroendocrine abnormalities precede symptom onset or develop secondarily?
Are neuroendocrine changes sufficient to explain all manifestations of ME/CFS, or are other biological systems (immune, mitochondrial, etc.) also involved?